Dr. Jonathan A. Ellman's lab at Yale University specializes in advanced methods for modifying C-H bonds in organic molecules to create new pharmaceuticals. Their research focuses on simplifying the synthesis of complex drug-like compounds from readily available materials and applying these techniques to discover new drugs targeting urgent medical needs. The lab emphasizes innovative strategies for efficient and selective production of biologically important molecules, particularly those interacting with specific receptors in the body.

Dr. Seth B. Herzon's lab at Yale University focuses on understanding and developing new treatments for cancer and drug-resistant bacterial infections. The research combines organic chemistry with biology to analyze the structures and functions of natural products and synthetic compounds, aiming to create novel therapeutics for targeted therapy. By exploring both the molecular mechanisms of these substances and their clinical applications, the lab seeks to address significant health challenges in oncology and antimicrobial resistance.

Scott J Miller's lab at Yale University focuses on developing new catalysts and chemical reactions to modify complex bioactive molecules, which are essential in drug discovery. The research aims to create efficient methods for synthesizing and diversifying drug candidates by targeting specific functional groups in these molecules. Overall, their work is poised to significantly advance the field of medicinal chemistry, particularly in creating novel therapeutics.